Background. Previous population-based estimates in the United States have shown a relatively high prevalence of hepatitis E virus (HEV) antibody. We sought to determine whether changes in the prevalence of HEV antibody have occurred over time.
Hepatitis E in developed countries is now recognized as a disease with unique clinical and epidemiological characteristics [1, 2] . In contradistinction to developing countries, where both sporadic and epidemic cases of hepatitis E occur from drinking water contaminated by feces of persons infected with hepatitis E virus (HEV) or from person-to-person spread [3, 4] , in developed countries it can be a foodborne zoonosis resulting from consumption of raw or undercooked meat and offal of HEV-infected pigs, boars, and deer [5] [6] [7] [8] . There is also evidence suggesting that HEV may be transmitted by eating fecally contaminated shellfish [9, 10] .
A previous study by Kuniholm et al estimated that the prevalence of immunoglobulin G (IgG) antibody to HEV in the United States was 21% (95% confidence interval [CI], 19%-22.9%), based on testing persons who participated in the Third National Health and Nutrition Examination Survey (NHANES III) during 1988-1994 [11] . Similar high seroprevalences have been documented among blood donors, veterinary workers, persons with chronic liver disease, and injection drug users sampled from different parts of the United States [11] [12] [13] [14] [15] . Further, the force of incident infection with HEV in the United States has been estimated to be 7 infections per 1000 susceptible persons per year [16] .
However, these study findings do not align with acute hepatitis E encountered in the United States. To date, few cases of locally acquired acute hepatitis E have been documented in the United States [17] , even among immunocompromised persons [18] , with the exception of recipients of solid-organ transplants [19, 20] and persons with presumed drug-induced liver toxicity [21] or chronic liver disease [22] . Moreover, for persons with a diagnosis of incident hepatitis E, no definitive link with known foods or recreational activities has been established [17] [18] [19] [20] [21] , unlike cases reported from Japan [5, 6, 8] or France [7] .
Another factor confounding the understanding of the epidemiology of hepatitis E in the United States relates to differences in performance characteristics of serologic assays used for detecting anti-HEV antibodies, particularly of the IgG class, whose presence in peripheral blood signifies prior HEV exposure or infection [23] [24] [25] [26] [27] [28] . Few studies have compared the prevalence of anti-HEV IgG over time by using the same serologic assay, and none were population based [24] . We report here findings of a study using a single serological assay to determine the prevalence of anti-HEV IgG among NHANES participants and to determine whether changes occurred from 1988-1994 to 2009-2010, and to identify factors associated with seropositivity for both periods, particularly among 2009-2010 participants, from whom information on potential food-associated risks (ie, shellfish consumption) was available.
METHODS

Survey Design
The NHANES, conducted by the Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS), collects nationally representative data on the health and nutritional status of the US noninstitutionalized civilian population. NHANES uses a complex, stratified, multistage probability sampling design and collects information by using standardized interviews, physical examinations, and tests of biologic samples. For NHANES III, data were collected from nearly 30 000 persons from 1988 through 1994; for NHANES 2009-2010, data were collected from approximately 5000 persons per year. Participants were interviewed in their homes by using the Computer-Assisted Personal Interviewing (intervieweradministered) system to ascertain demographic characteristics and in the Mobile Examination Center to ascertain possible risks and exposures for HEV infection. Persons aged ≥16 years and emancipated minors were interviewed directly; an adult proxy provided information for participants aged <16 years and for individuals unable to answer the questions themselves. All participants provided written informed consent. More detailed information on survey design for NHANES, including institutional review board approval is accessible on the NHANES Web site (http://www.cdc.gov/nchs/nhanes/nhanes_ questionnaires.htm).
Subsampling of NHANES III Participants
A subset of NHANES III specimens was chosen by selecting a stratified random sample of 6000 participants, using SAS ProcSurvey Select (SAS, version 9.2; SAS Institute, Cary, NC). After consideration of the estimated standard errors and confidence interval (CI) half-widths that might be obtained for variables of interest with sample sizes ranging from 1000 to 6000, a sample size of 6000 was chosen because that was expected to allow estimation of the anti-HEV IgG prevalence, stratified by select demographic characteristics, with a precision comparable to that of the estimates of Kuniholm et al [11] . All NHANES III participants aged ≥6 years who had an anti-HEV antibody result from that study and a positive sampling weight were eligible for sampling. Sampling was stratified on the basis of the test results obtained by Kuniholm et al ( positive or negative), to sample specimens with a positive result at a higher rate. Unequal probability of selection was conducted to ensure a sufficient number of positive results for statistical analysis should a lower antibody prevalence be found by means of the serological assay we used. Thus, unweighted prevalence will differ greatly from weighted prevalence estimates.
Laboratory Testing
Serological testing was performed using the anti-HEV IgG assay manufactured by Diagnostic System (DSI, Saronno, Italy). Samples that were initially reactive were retested in duplicate for confirmation. The analytical sensitivity of the DSI assay was 1.6 IU/mL, as determined by using serial dilutions of the World Health Organization Reference Reagent for Hepatitis E Virus Antibody (code 95/584; 100 IU/mL, purchased from the National Institute of Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom). Specificity was evaluated using a panel consisting of 1008 NHANES sera tested by the DSI assay and an in-house Western blotting assay, which found that among 890 DSI-reactive samples, 863 were reactive by Western blotting, thereby giving a 97% concordance (unpublished data).
Statistical Analysis
SAS-callable SUDAAN (version 11.0), a statistical package designed to analyze complex survey data, was used for analysis. Estimates were weighted to represent the total US noninstitutionalized civilian population and to account for oversampling and nonresponse to the household interview and physical examination. Weights (WTPFEX6) for the subsample of NHANES III participants were adjusted to account for the fact that not all NHANES III participants were tested for HEV antibody by Kuniholm et al [11] and were further adjusted for the unequal selection probabilities for subsampling by multiplying the initially adjusted WTPFEX6 weight by the subsampling weight from SAS ProcSurvey Select. A P value of < .05 was considered significant.
We used repeated reactivity by the DSI assay as measure of persons ever exposed to HEV. In addition to demographic characteristics such as age, sex, race/ethnicity, place of birth, and region of residence, our analysis also included risks and exposures investigated by Kuniholm et al [11] , noting that some risks and exposures included in their analysis were slightly different for NHANES 2009-2010 participants, owing to differences in questionnaire content between the 2 surveys. In particular, more-detailed questions concerning frequency of shellfish consumption were added to the questionnaire for 2009-2010.
Bivariate analyses were used to estimate the anti-HEV IgG prevalence by demographic characteristics, and the prevalence of potential risk factors or exposures among population subgroups. χ 2 tests were used for statistical comparisons between subgroups within a given period. CIs were used to compare prevalence across surveys, with differences being considered significant if the estimate for the later survey was not included in the 95% CI of the corresponding estimate from the earlier survey. Potential risk factors and exposures were investigated only for those who reported having been born in the United States. Simple and multivariate logistic regression models were used to identify factors associated with anti-HEV IgG positivity. Separate logistic analyses controlling for age, sex, race/ethnicity, and region of residence were performed for each risk factor or exposure. Although some variables in our analyses were age dependent (ie, based on the age eligibility for certain tests or questions), we maintained, to the extent possible, consistency with those used in the analysis by Kuniholm et al [11] . Differences in risk factors over time were assessed by comparing the significance of the factor within each survey. Because variables for region of residence and metro/nonmetro residence were not available in the public use data for NHANES 2009-2010, analyses were performed in the NCHS' Restricted Data Center (RDC). To protect participant confidentiality, analyses for small subgroups are not released by the RDC; thus, no results are available for male-to-male sex as a risk factor. Figure 1 ). Among all participants and US-born participants, the estimated anti-HEV IgG prevalence between the 2 study periods declined significantly for all subgroups age group and sex (Tables 1 and 2 ). Among the US-born participants, declines also were found by region of residence, by number of persons per room in the household, among persons at or above poverty level, for those residing in both metropolitan and nonmetropolitan areas, and for those of non-Hispanic white, non-Hispanic black, or Mexican American race/ethnicity (Table 2) . For both surveys, age, race/ethnicity, region of residence, number of persons per room in the household, and income were significantly associated with anti-HEV IgG positivity, with lower prevalence among younger persons, residents of the South, those below the poverty level, and those living in more-crowded conditions and higher prevalence among non-Hispanic whites (Table 2) .
RESULTS
Of
For the 1988-1994 participants, risk factors associated with higher antibody prevalence in bivariate (χ 2 ) analyses were military service, never having used cocaine or crack, less frequent consumption of processed meats, and hepatitis A virus (HAV) antibody positivity. After adjustment for age, sex, race/ethnicity, and region of residence, only anti-HAV positivity remained significantly associated with anti-HEV positivity (Table 3) . For the 2009-2010 participants, higher antibody prevalence was significantly associated in bivariate analyses with having a well, cistern, or spring as the source of tap water for drinking; with less frequent consumption of processed meats; and with more-frequent consumption of green leafy vegetables or lettuce salad. Not drinking tap water was significantly associated with a lower antibody prevalence. After adjustment for age, sex, race/ethnicity, and region of residence, the only risk factor significantly associated with seropositivity was more-frequent consumption of processed meats, but this factor was protective (Table 3) .
DISCUSSION
The estimated overall anti-HEV IgG prevalence in the United States declined by approximately 40% from 1988-1994 (10.2%) to 2009-2010 (6.0%). The prevalence decreased across age groups, sex, race/ethnicity, country of birth, and region of residence. The higher prevalence among older persons in both periods despite the decline in prevalence for all age groups may indicate that exposures to and infections by HEV are occurring at a lower rate in younger persons. Persons who live in crowded situations and below the poverty line were found to have a significantly lower prevalence than those who live in less crowded situations and lived at or above the poverty line. These findings suggest that HEV infection may be associated with relative affluence. However, the nature of affluent lifestyle or behavior that would lead to HEV infection remains to be identified.
Among NHANES participants from both study periods, less frequent consumption of processed meats was associated with higher seropositivity rates. Such lesser frequency, however, would not mean more-frequent consumption of nonprocessed meats, which would include meats that were eaten raw or inadequately cooked, nor would consumption of meat (whether processed or not) necessarily relate to affluence. Nonetheless, the finding of an association between more-frequent consumption of green leafy vegetables or lettuce salad and higher rate of anti-HEV prevalence among NHANES 2009-2010 participants might possibly reflect the preference by more-affluent participants for organic food products, but that possibility remains speculative. Detailed inquiry into shellfish consumption habits among the NHANES 2009-2010 participants did not generate significant associations, although the questions did not cover the eating of filter-feeding bivalves other than oysters and clams, such as mussels and cockles, that inhabit shallow water beds or the consumption of raw shellfish [29] .
The high anti-HEV prevalence reported from developed countries, where hepatitis E outbreaks are not observed, remains to be explained. One possibility is the poor sensitivity and specificity of anti-HEV IgG assays used in seroprevalence studies of populations at low risk of HEV infection, such as Abbreviation: CI, confidence interval. a Results are for a random subsample of NHANES III specimens tested with the DSI assay. Because of unequal probabilities of selection, unweighted prevalences will differ greatly from weighted prevalence estimates. b P < .001, by the χ 2 test, within a given period.
c P < .01, by the χ 2 test, within a given period.
d Estimate has a relative standard error (RSE) of >30%. Estimates with a RSE of >30% and estimates based on <10 positive persons may be unstable and should be interpreted with caution. e P < .05, by the χ 2 test, within a given period. Table 3 . [1988] [1989] [1990] [1991] [1992] [1993] [1994] blood donors and persons drawn from the general community. In such contexts, studies have shown substantial differences in the performance of anti-HEV IgG assays [22, 25, 27, 28] . Our current study, in which we used the DSI assay for analysis of the 1988-1994 NHANES III specimens, showed a prevalence of 10.2%, which is lower than the 21% prevalence reported by Kuniholm et al [11] . This disparity could be due to differences in performances between the assays applied.
This study has the following limitations. First, NHANES data are only generalizable to the US noninstitutionalized civilian population because it excludes homeless individuals, persons living in correctional institutions, and individuals living in other group quarters (eg, students living in dormitories and military recruits). Second, small sample sizes for some of the variables may have limited our power to detect statistically significant differences between subgroups. Third, the self-reported Ages included for each variable will vary depending on age eligibility for a particular question or laboratory test.
Abbreviations: CI, confidence interval; HAV, hepatitis A virus; HBc, hepatitis B virus core antigen; HCV, hepatitis C virus; ND, not determined in the survey. a Results from a random subsample of NHANES III specimens tested with the DSI assay. Because of unequal probabilities of selection, unweighted prevalences will differ greatly from weighted prevalence estimates. b Adjusted for age, sex, race, and region of residence.
c Among participants aged >17 years. information is subject to recall bias. Fourth, the level of detail regarding some of the dietary questions was limited to frequency of consumption and lacked important information that may contribute to risk (eg, whether shellfish was consumed cooked or raw), thus limiting our ability to find significant associations even for those dietary sources of infection that are already known. Finally, the duration of IgG anti-HEV after exposure is not well known. In a serological follow up of 320 persons known to have hepatitis E during an outbreak, 50% of the cases still had detectable anti-HEV IgG 14 years later [30] . It remains unknown whether the antibody prevalence in our study populations is a result of recent or remote infection. Nonetheless, given the lower antibody prevalence in younger persons, the higher prevalence in the older population is likely a result of infection that took place in the remote past.
In conclusion, our data show a decline in the seroprevalence of anti-HEV in the United States from 1988-1994 to 2009-2010, but the prevalence is still relatively high, at 6.0%. Whether this decline is a consequence of factors such as a decrease in exposure of susceptible persons due to lifestyle or behavioral changes or a change in the etiologic agent over time remains to be answered.
